Life after the lead asset: Advancing an early-stage pipeline

from BioSpace · host BioSpace

In this episode of Denatured presented by Arvinas, Jennifer Smith-Parker speaks to Arvinas President and CEO Randy Teel about the strategic discipline and leadership required to successfully refocus a company on an early-stage pipeline after a lead asset is outlicensed, discontinued or otherwise falls away — an inflection point many biotech and pharma companies face, but few navigate effectively.This episode is presented in partnership with Arvinas. HostJennifer Smith-Parker, Director of Insights, BioSpaceGuestRandy Teel, President and CEO, Arvinas

Episode metadata supplied by the publisher feed · Published Jul 30, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Life after the lead asset: Advancing an early-stage pipeline

0:00 24:01

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of BioSpace?

This episode is 24 minutes long.

When was this BioSpace episode published?

This episode was published on July 30, 2026.

Can I download this BioSpace episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!